Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Peripheral Arterial Hemorrhage clinical trials

1 of 1 indexed Peripheral Arterial Hemorrhage trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Peripheral Arterial Hemorrhage: 1 US clinical trial tracked, 1 recruiting.

Peripheral Arterial Hemorrhage is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Medtronic Endovascular, running 1 of these trials.

Enrollment posture brief

Registry condition peripheral-arterial-hemorrhage

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Peripheral Arterial Hemo (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Peripheral Arterial Hemorrhage

Peripheral Arterial Hemorrhage lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Peripheral Arterial Hemorrhage on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Peripheral Arterial Hemorrhage is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Peripheral Arterial Hemorrhage records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Onyx™ Liquid Embolic System Device
1 trials

US sites by state

Facility locations filed on Peripheral Arterial Hemorrhage trials. A trial with sites in several states counts in each.

Texas 1 trials
Tennessee 1 trials
Ohio 1 trials
New York 1 trials
Nebraska 1 trials
Massachusetts 1 trials
Iowa 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Peripheral Arterial Hemorrhage page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Peripheral Arterial Hemorrhage trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Medtronic Endovascular sponsors the most Peripheral Arterial Hemorrhage trials on record, review their full trial history before evaluating a specific study. See Medtronic Endovascular's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peripheral Arterial Hemorrhage condition card totals 1 registered trials; most-linked intervention Onyx™ Liquid Embolic System; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.